Skip to main content
VB

Verb Biotics

Verb Biotics develops targeted probiotic strains and bioactive ingredients to enhance microbiome health, addressing issues related to digestive health, stress, and immune response. Their function-first approach utilizes intentional research to create clinically-validated solutions for specific health needs in food, beverage, and supplement applications.

Boston, United StatesFounded 2021202K+ followers
Updated 4 months ago

Funding

$60M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Existing probiotic solutions often lack specificity and proven efficacy, relying on generic strains and colony-forming units (CFUs) as a proxy for potency. Many products fail to address specific health needs with targeted mechanisms of action, leading to inconsistent results for consumers.

Solution

Verb Biotics develops function-first bioactives, including probiotics and postbiotics, designed to deliver specific health benefits by targeting the microbiome. The company utilizes a science-driven approach, starting with the desired health outcome and then identifying and scaling bioactive solutions that provide a specific mechanism of action. Their ingredients are developed to address common and complex health states, such as digestive health, stress and mood, healthy aging, sports recovery, and women’s health. Verb Biotics combines science, biotechnology, and intentional development to deliver clinically-validated ingredients for food, beverage, and supplement brands.

Target Audience

Verb Biotics serves food, beverage, and supplement brands looking to differentiate their products with clinically-validated, function-first microbiome solutions.

Features

  • Keystone Postbiotic™: Balances and promotes the growth of keystone microflora in the microbiome to support a healthy immune response.
  • GABA Probiotic (LP815™): Provides sustained GABA (gamma-aminobutyric acid) for calming and stress support.
  • Function-first approach: Solutions are developed starting with the desired health outcome and working backward to identify the mechanism of action.
  • Whole Genome Sequencing (WGS): Meticulously combs through WGS data to ensure bacterial strains are safe and effective.
  • Solutions for functional beverages: Keystone Postbiotic™ is shelf and process-stable, making it easy to incorporate into a wide array of product applications, including sodas, shakes, powders, and juices.
This profile is AI-generated and may contain inaccuracies.